Seaport Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-03-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | ||
EBITDA | -27,186 | |
EBIT | -27,543 | |
Net Income | -25,408 | -13,125 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -20,172 | -20,259 |
Cash | 52,909 | |
Basic Shares | 53,027 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -85,889 | |
EBIT | -87,294 | |
Net Income | -74,881 | -46,879 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -78,298 | -29,742 |
Cash | 46,042 | 309,099 |
Basic Shares | 38,646 | 53,027 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.78 |
2026-03-31 | -$10.34 |